During the past decade, Harold Alfond Center for Cancer Care conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 65 clinical trials were completed, i.e. on average, 116.1% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 28 clinical trials were completed. i.e. 186.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Harold Alfond Center for Cancer Care" #1 sponsor was "National Cancer Institute (NCI)" with 69 trials, followed by "SWOG Cancer Research Network" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "NRG Oncology" with 8 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Harold Alfond Center for Cancer Care" #1 collaborator was "National Cancer Institute (NCI)" with 68 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Harold Alfond Center for Cancer Care" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Breast Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials) and "Invasive Breast Carcinoma" (6 trials). Many other conditions were trialed in "Harold Alfond Center for Cancer Care" in a lesser frequency.

Most popular intervention types in "Harold Alfond Center for Cancer Care" are "Drug" (117 trials), "Other" (100 trials), "Biological" (59 trials), "Procedure" (29 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (55 trials), "Quality-of-Life Assessment" (34 trials), "Questionnaire Administration" (22 trials), "Paclitaxel" (20 trials) and "Carboplatin" (15 trials). Other intervention names were less common.

The vast majority of trials in "Harold Alfond Center for Cancer Care" are 121 trials for "All" genders, 15 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Harold Alfond Center for Cancer Care". undefined are not yet recruiting, 22 are recruiting, 71 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Harold Alfond Center for Cancer Care, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Harold Alfond Center for Cancer Care, 2 "Phase 1" clinical trials were conducted, 57 "Phase 2" clinical trials and 82 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".